{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T22:15:17Z","timestamp":1787004917033,"version":"build-2736575974"},"reference-count":45,"publisher":"Georg Thieme Verlag KG","issue":"02","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Semin Thromb Hemost"],"published-print":{"date-parts":[[2025,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Factor V (FV) is a glycoprotein that plays a pivotal role in hemostasis, being involved in coagulant and anticoagulant pathways. Congenital FV deficiency is a rare bleeding disorder with an incidence of 1 per million live births, considering the most severe homozygous form. FV deficiency is diagnosed using routine coagulation tests and FV activity assays. Several mutations, including missense, nonsense, and frameshift, have been detected in the F5 gene. Clinical symptoms are variable, ranging from mild ecchymoses and mucosal bleeding to life-threatening intracranial hemorrhage. The mainstay of treatment includes fresh-frozen plasma, preferentially virus-inactivated. In this narrative review, we provide an update of the main laboratory, molecular, clinical, and therapeutic features of inherited FV deficiency.<\/jats:p>","DOI":"10.1055\/s-0044-1789021","type":"journal-article","created":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T19:33:25Z","timestamp":1724787205000},"page":"111-115","source":"Crossref","is-referenced-by-count":5,"title":["Clinical, Laboratory, and Molecular Aspects of Factor V Deficiency"],"prefix":"10.1055","volume":"51","author":[{"given":"Massimo","family":"Franchini","sequence":"additional","affiliation":[{"name":"Department of Hematology and Transfusion Medicine, Carlo Poma Hospital, Mantua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Focosi","sequence":"additional","affiliation":[{"name":"North-Western Tuscany Blood Bank, Pisa University Hospital, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2024,8,27]]},"reference":[{"issue":"05","key":"ref1","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1055\/s-0039-1687906","article-title":"A comprehensive overview of coagulation factor V and congenital factor V deficiency","volume":"45","author":"S Tabibian","year":"2019","journal-title":"Semin Thromb Hemost"},{"issue":"08","key":"ref2","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/j.biocel.2003.08.002","article-title":"Coagulation factor V","volume":"36","author":"S Duga","year":"2004","journal-title":"Int J Biochem Cell Biol"},{"issue":"07","key":"ref3","first-page":"24","article-title":"The magic of proteases: from a procoagulant and anticoagulant factor V to an equitable treatment of its inherited deficiency","volume":"24","author":"J A De Pablo-Moreno","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"05","key":"ref4","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1097\/MOH.0b013e3283497ebc","article-title":"A new look at blood coagulation factor V","volume":"18","author":"R M Camire","year":"2011","journal-title":"Curr Opin Hematol"},{"issue":"S 01","key":"ref5","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/ijlh.12508","article-title":"Pro- and anticoagulant properties of factor V in pathogenesis of thrombosis and bleeding disorders","volume":"38","author":"B Dahlb\u00e4ck","year":"2016","journal-title":"Int J Lab Hematol"},{"issue":"12","key":"ref6","doi-asserted-by":"crossref","first-page":"4593","DOI":"10.1182\/blood.V91.12.4593","article-title":"The structure and function of murine factor V and its inactivation by protein C","volume":"91","author":"T L Yang","year":"1998","journal-title":"Blood"},{"issue":"03","key":"ref7","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/MBC.0b013e3283424883","article-title":"Inherited and acquired factor V deficiency","volume":"22","author":"G Lippi","year":"2011","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"04","key":"ref8","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.jtha.2023.01.033","article-title":"Natural anticoagulant discovery, the gift that keeps on giving: finding FV-Short","volume":"21","author":"B Dahlb\u00e4ck","year":"2023","journal-title":"J Thromb Haemost"},{"issue":"04","key":"ref9","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1055\/s-0029-1225756","article-title":"Rare bleeding disorders","volume":"35","author":"F Peyvandi","year":"2009","journal-title":"Semin Thromb Hemost"},{"issue":"04","key":"ref10","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1055\/s-0029-1225760","article-title":"Factor V deficiency","volume":"35","author":"R Asselta","year":"2009","journal-title":"Semin Thromb Hemost"},{"issue":"6449","key":"ref11","first-page":"446","article-title":"Parahaemophilia; haemorrhagic diathesis due to absence of a previously unknown clotting factor","volume":"1","author":"P A Owren","year":"1947","journal-title":"Lancet"},{"issue":"01","key":"ref12","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1538-7836.2006.02258.x","article-title":"An online database of mutations and polymorphisms in and around the coagulation factor V gene","volume":"5","author":"H L Vos","year":"2007","journal-title":"J Thromb Haemost"},{"issue":"06","key":"ref13","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1055\/s-0033-1349224","article-title":"Parahemophilia: new insights into factor v deficiency","volume":"39","author":"N Thalji","year":"2013","journal-title":"Semin Thromb Hemost"},{"issue":"05","key":"ref14","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1182\/blood.V86.5.1820.bloodjournal8651820","article-title":"Factor VNew Brunswick: Ala221-to-Val substitution results in reduced cofactor activity","volume":"86","author":"J M Murray","year":"1995","journal-title":"Blood"},{"issue":"08","key":"ref15","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1182\/blood-2003-04-1225","article-title":"The murine platelet and plasma factor V pools are biosynthetically distinct and sufficient for minimal hemostasis","volume":"102","author":"H Sun","year":"2003","journal-title":"Blood"},{"issue":"04","key":"ref16","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1080\/10245332.2016.1263007","article-title":"Diagnosis, clinical manifestations and management of rare bleeding disorders in Iran","volume":"22","author":"A Dorgalaleh","year":"2017","journal-title":"Hematology"},{"issue":"06","key":"ref17","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1055\/s-0033-1349223","article-title":"Combined deficiency of coagulation factors V and VIII: an update","volume":"39","author":"C Zheng","year":"2013","journal-title":"Semin Thromb Hemost"},{"issue":"04","key":"ref18","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1055\/s-0029-1225761","article-title":"Combined factor V and factor VIII deficiency","volume":"35","author":"M Spreafico","year":"2009","journal-title":"Semin Thromb Hemost"},{"issue":"07","key":"ref19","first-page":"474","article-title":"Combined factor V and factor VIII deficiency","volume":"10","author":"G A Soff","year":"2012","journal-title":"Clin Adv Hematol Oncol"},{"issue":"06","key":"ref20","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.hoc.2021.07.010","article-title":"Rare coagulation factor deficiencies (factors VII, X, V, and II)","volume":"35","author":"G Batsuli","year":"2021","journal-title":"Hematol Oncol Clin North Am"},{"issue":"S 01","key":"ref21","first-page":"S37","article-title":"The rare inherited coagulation disorders","volume":"60","author":"P H Bolton-Maggs","year":"2013","journal-title":"Pediatr Blood Cancer"},{"issue":"01","key":"ref22","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.drudis.2017.11.002","article-title":"Rare genetic diseases: update on diagnosis, treatment and online resources","volume":"23","author":"R E Pogue","year":"2018","journal-title":"Drug Discov Today"},{"issue":"11","key":"ref23","doi-asserted-by":"crossref","first-page":"e24705","DOI":"10.1002\/jcla.24705","article-title":"Congenital coagulation factor V deficiency with intracranial hemorrhage","volume":"36","author":"J Yang","year":"2022","journal-title":"J Clin Lab Anal"},{"issue":"04","key":"ref24","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1046\/j.1365-2141.1998.01077.x","article-title":"Symptoms of inherited factor V deficiency in 35 Iranian patients","volume":"103","author":"M Lak","year":"1998","journal-title":"Br J Haematol"},{"issue":"08","key":"ref25","first-page":"e17047","article-title":"Owren's disease: a rare deficiency","volume":"13","author":"M Ehtisham","year":"2021","journal-title":"Cureus"},{"issue":"02","key":"ref26","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s12288-012-0149-8","article-title":"Factor V deficiency associated with congenital cardiac disorder and intracranial hemorrhage","volume":"29","author":"H Ozkaya","year":"2013","journal-title":"Indian J Hematol Blood Transfus"},{"issue":"17","key":"ref27","doi-asserted-by":"crossref","first-page":"331","DOI":"10.21037\/atm.2018.08.34","article-title":"Rare congenital bleeding disorders","volume":"6","author":"M Franchini","year":"2018","journal-title":"Ann Transl Med"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1471-2431-7-8","article-title":"A neonatal presentation of factor V deficiency: a case report","volume":"7","author":"A Chingale","year":"2007","journal-title":"BMC Pediatr"},{"issue":"02","key":"ref29","doi-asserted-by":"crossref","first-page":"e482","DOI":"10.1097\/MPH.0000000000002261","article-title":"Clinical phenotype and genetic analysis of twins with congenital coagulation factor V deficiency","volume":"44","author":"Y Wei","year":"2022","journal-title":"J Pediatr Hematol Oncol"},{"issue":"10","key":"ref30","first-page":"1150","article-title":"Endogenous factor V synthesis in megakaryocytes contributes negligibly to the platelet factor V pool","volume":"88","author":"M C Thomassen","year":"2003","journal-title":"Haematologica"},{"issue":"04","key":"ref31","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1074\/jbc.M308600200","article-title":"Unique in vivo modifications of coagulation factor V produce a physically and functionally distinct platelet-derived cofactor: characterization of purified platelet-derived factor V\/Va","volume":"279","author":"W R Gould","year":"2004","journal-title":"J Biol Chem"},{"issue":"35","key":"ref32","doi-asserted-by":"crossref","first-page":"20794","DOI":"10.1074\/jbc.270.35.20794","article-title":"The mechanism of inactivation of human platelet factor Va from normal and activated protein C-resistant individuals","volume":"270","author":"R M Camire","year":"1995","journal-title":"J Biol Chem"},{"issue":"09","key":"ref33","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.1182\/blood-2008-06-162453","article-title":"Low plasma levels of tissue factor pathway inhibitor in patients with congenital factor V deficiency","volume":"112","author":"C Duckers","year":"2008","journal-title":"Blood"},{"issue":"04","key":"ref34","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1056\/NEJM199807233390407","article-title":"Hemostatic drugs","volume":"339","author":"P M Mannucci","year":"1998","journal-title":"N Engl J Med"},{"issue":"06","key":"ref35","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/MOH.0000000000000084","article-title":"Adjunct agents for bleeding","volume":"21","author":"M Franchini","year":"2014","journal-title":"Curr Opin Hematol"},{"issue":"05","key":"ref36","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.3324\/haematol.2020.250720","article-title":"The never ending success story of tranexamic acid in acquired bleeding","volume":"105","author":"M Franchini","year":"2020","journal-title":"Haematologica"},{"issue":"04","key":"ref37","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3390\/jcm6040045","article-title":"Diagnosis and treatment of von Willebrand disease and rare bleeding disorders","volume":"6","author":"G Castaman","year":"2017","journal-title":"J Clin Med"},{"issue":"05","key":"ref38","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1182\/blood-2018-06-820738","article-title":"Treatment of rare factor deficiencies other than hemophilia","volume":"133","author":"M Menegatti","year":"2019","journal-title":"Blood"},{"issue":"03","key":"ref39","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1586\/17474086.2015.1016906","article-title":"Solvent\/detergent-treated plasma: a tale of 30 years of experience","volume":"8","author":"G M Liumbruno","year":"2015","journal-title":"Expert Rev Hematol"},{"issue":"04","key":"ref40","first-page":"277","article-title":"Is solvent\/detergent plasma better than standard fresh-frozen plasma? A systematic review and an expert consensus document","volume":"14","author":"M Marietta","year":"2016","journal-title":"Blood Transfus"},{"issue":"03","key":"ref41","first-page":"342","article-title":"Hemostatic agents for bleeding: recombinant-activated factor VII and beyond","volume":"41","author":"M Franchini","year":"2015","journal-title":"Semin Thromb Hemost"},{"issue":"07","key":"ref42","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1111\/trf.15322","article-title":"Platelet transfusion as treatment for factor V deficiency in the parturient: a case report","volume":"59","author":"D M Drzymalski","year":"2019","journal-title":"Transfusion"},{"issue":"S 01","key":"ref43","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1046\/j.1365-2516.2001.00100.x","article-title":"Current therapy for rare factor deficiencies","volume":"7","author":"J Di Paola","year":"2001","journal-title":"Haemophilia"},{"issue":"S 01","key":"ref44","first-page":"848","article-title":"In vitro study of a new plasma-derived factor V (FV) concentrate: dose-response evaluation in plasma from patients with congenital FV deficiency","volume":"1","author":"P Simioni","year":"2017","journal-title":"Res Pract Thromb Haemost"},{"issue":"04","key":"ref45","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/hae.13465","article-title":"\u201cIn vitro\u201d correction of the severe factor V deficiency-related coagulopathy by a novel plasma-derived factor V concentrate","volume":"24","author":"C Bulato","year":"2018","journal-title":"Haemophilia"}],"container-title":["Seminars in Thrombosis and Hemostasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0044-1789021.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T18:41:19Z","timestamp":1739990479000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0044-1789021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,27]]},"references-count":45,"journal-issue":{"issue":"02","published-online":{"date-parts":[[2025,2,19]]},"published-print":{"date-parts":[[2025,3]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0044-1789021","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0094-6176","1098-9064"],"issn-type":[{"value":"0094-6176","type":"print"},{"value":"1098-9064","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,27]]}}}